Skip to content
TrialScanner

NCT03588078

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

Phase 1/Phase 2CompletedAPRECollaborator

Registry record

Lead sponsor
Groupe Francophone des Myelodysplasies
Conditions
Myelodysplastic Syndrome With Gene Mutation; Acute Myeloid Leukemia With Gene Mutations; Myeloproliferative Neoplasm; Chronic Myelomonocytic Leukemia
Primary completion
May 1, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03588078 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03588078: Study of the Safety and... | TrialScanner